Home
News

Research showing the efficacy of a new three-drug cocktail that may help to treat ALS or Lou Gehrig's disease

Published: 28 March 2003

You are invited to the announcement of breakthrough research showing the efficacy of a new three-drug cocktail that may help to treat ALS or Lou Gehrig's disease.

ALS is a steadily progressive and fatal neuromuscular disease that affects 1,500 to 2,000 people in Canada.

Two to three Canadians a day die of ALS.

Conducted at the Research Institute of the McGill University Health Centre and funded by the ALS Society of Canada and its partners in neuromuscular research, this research provides hope for people living with this devastating disease.

Date :

Tuesday, April 1, 2003

When :

10:30 a.m.

Where :

Osler Amphitheatre
6th Floor, Cedar Ave Entrance
Montreal General Hospital
1650 Cedar Ave

Who :

Dr. Jean-Pierre Julien
Research Institute of the McGill University Health Centre

Dr. Angela Genge
Director of the ALS Clinic, Montreal Neurological Institute and Hospital, McGill University, MUHC

Dr. Monique D'Amour
Neurologist and primary investigator of ALS
Centre Hospitalier de l'Université de Montréal

Dr. Rémi Quirion
Scientific Director, Canadian Institutes of Health Research's Institute of Neurosciences, Mental Health and Addiction

Helene Vassos
ALS Society of Canada

Several people living with ALS will also be available for interviews.

Contact Information

Contact: 
Christine Zeindler
Organization: 
MUHC Public Relations and Communications
Email: 
christine.zeindler [at] muhc.mcgill.ca
Office Phone: 
514-934-1934 ext. 36419
Category: 
Mon, 09/03/2012 - 07:52
Source Site: 
/channels
Back to top